Ensysce Biosciences Inc ENSC shares are trading lower by 51.12% to $1.09 Wednesday morning after the comnpany announced pricing of a $4.1 million public offering.
What Happened?
Ensysce Biosciences says the offering is expected to close on or about December 9, subject to satisfaction of customary closing conditions.
20% of the gross proceeds of the offering will be used to repay a portion of the company's outstanding convertible notes. The company intends to use the remaining net proceeds from the offering for the further clinical development of its product candidates and for working capital and other general corporate purposes.
See Also: Why Li Auto, Nio And XPeng Shares Are Falling
According to data from Benzinga Pro, ENSC has a 52-week high of $140.00 and a 52-week low of $1.05.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
